La XI Conferencia Internacional de Evaluación de Impacto en Salud (EIS), que este año se celebra en Granada bajo el lema ‘En tiempos de crisis, salidas más saludables’, llega mañana a su segunda y última jornada con un programa donde expertos de diferentes países analizarán el papel de la evaluación de impacto en las políticas sanitarias, así como en la promoción de la salud en países en desarrollo.
La Evaluación de Impacto en Salud (EIS) es una herramienta fundamental en salud pública para planificar las políticas en base al impacto que estas puedan tener para el bienestar de los ciudadanos. La Organización Mundial de la Salud (OMS) la define como "una combinación de procedimientos, métodos e instrumentos que permiten juzgar los posibles efectos de una política, un programa o proyecto en la salud de una población, y la distribución de los potenciales efectos dentro de ella".
Durante las diferentes sesiones, los expertos también abordarán la necesidad del desarrollo de enfoques integrados para obtener resultados más positivos en torno a la equidad en salud, así como el futuro de la EIS como una herramienta de gobernanza intersectorial.
José Martínez Olmos, secretario general de Sanidad del Ministerio de Sanidad, Política Social e Igualdad, será el encargado de clausurar una jornada protagonizada por expertos de más de 12 países que pondrán sobre la mesa diferentes experiencias sobre el desarrollo de la Evaluación de Impacto en Salud, así como los resultados obtenidos y la posibilidad de nuevos enfoques.
-Bajiv Bhatia, director del área de Salud ocupacional y ambiental del Departamento de Salud Pública de San Francisco; Alain Poirier, director Nacional de Salud Pública y Viceministro en el Ministerio de Salud y Servicios Sociales de Québec; Laetitia Kuijpers, coordinadora de políticas en el Ministerio de Salud, Bienestar y Deportes de los Países Bajos; y Taru Koivisto, directora de Promoción de la Salud del Ministerio de Asuntos Sociales y Salud en Finlandia, protagonizarán la primera mesa de la jornada, centrada en el ‘Desarrollo e institucionalización de la EIS en el proceso de la toma de decisiones’. En este sentido, durante la mesa se analizarán las experiencias de diferentes países en la integración de la EIS en el proceso de la toma de decisiones, dando así la oportunidad a todos los asistentes de aprender de los errores y aprovechar oportunidades que han funcionando en otros contextos.
-Enfoques integrados
En un momento en el que las desigualdades en salud dentro de y entre poblaciones están creciendo, "es alentador que algunos gobiernos vean la equidad en salud como un indicador de su éxito", ha explicado Marilyn Wise, una de las ponentes que participarán en la segunda mesa de la jornada. No obstante, Wise, con más de 25 años de experiencia en promoción de la salud, ha puesto de manifiesto las dificultades para avanzar en el funcionamiento con otros sectores de una forma eficaz, existiendo aún pocos ejemplos de mejoras. Por ello, "es esencial el desarrollo enfoques integrados en las evaluaciones de impacto", tema que va a centrar la segunda sesión de la jornada.
Rainer Fehr, director del Departamento de Prevención e Innovación del Instituto de Salud y Trabajo (Renania del Norte) y del WHO Collaborating Center for Regional Health Policy and Public Health; Izabella Rohlfs, epidemióloga en la Unidad de Planificación del Servicio Catalán de la Salud y consultora experta en Género y Salud y Marilyn Wise, profesora de Políticas Públicas Saludables en el Centre for Health Equity Training Research and Evaluation (CHETRE) en la Universidad de Nueva Gales del Sur (Australia) serán los encargados de analizar el impacto de la crisis en la equidad de la salud y la distribución de los determinantes en salud. En este sentido, se abordará el desarrollo de enfoques integrados en las evaluaciones de impacto como una fórmula para alcanzar condiciones de equidad en salud, así como resultados positivos en la distribución de los determinantes en salud, creando así "un mundo en el cual todos tenemos las mismas oportunidades de sobrevivir y prosperar", ha adelantado Wise.
-Promoviendo la salud en países en desarrollo
La Ayuda Oficial al Desarrollo (ODA) alcanzó en 2010 los 126.000 millones de dólares aproximadamente. En este contexto, las evaluaciones de impacto son consideradas herramientas apropiadas para reducir al mínimo los efectos adversos y promover los aspectos positivos como nuevas estrategias, políticas, programas o proyectos para favorecer el crecimiento de países en vías de desarrollo. Éste será el tema que centrará la tercera sesión de la jornada, en la que participarán Carlos Dora, coordinador del Programa global de Evaluación del Impacto en Salud en el Departamento de Salud Pública y Medio Ambiente de la OMS; Peter Furu, del Centro de Investigación y Desarrollo en Salud de la Universidad de Copenhague; Sergio Galán, jefe de Área de Salud de la Agencia Española de Cooperación Internacional y Juan Garay, de la Dirección de Desarrollo de la Comisión Europea.
-La EIS, herramienta de gobernanza intersectorial
La última jornada de la XI Conferencia Internacional de Evaluación del Impacto en la Salud llega a su fin con una mesa donde siete expertos de diferentes países como Finlandia, Bélgica, Italia o Alemania, analizarán el futuro de la EIS como una herramienta de gobernanza intersectorial. Para ello se contará con la presencia de Antonio Duran, consultor en Salud Pública y Sistemas Sanitarios (España); Josep Figueras, Director del Observatorio Europeo de Sistemas y Políticas de Salud de la OMS en Bruselas; John Kemm, consultor en Salud Pública y EIS (Inglaterra); Taru Koivisto, directora de Promoción de la Salud del Ministerio de Asuntos Sociales y Salud en Finlandia; Isabel de la Mata, asesora principal en materia de Salud Pública en la DG SANCO –Sanidad y Protección de los Consumidores-; Matthias Wismar, analista experto en Políticas de Salud en el Observatorio Europeo de Sistemas y Políticas de Salud.
Diario digital con noticias de actualidad relacionadas con el mundo de la salud. Novedades, encuestas, estudios, informes, entrevistas. Con un sencillo lenguaje dirigido a todo el mundo. Y algunos consejos turísticos para pasarlo bien
Traductor
14 April 2011
Experimental treatment for COPD in development
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study published in the April 13 edition of the journal Science Translational Medicine, the Johns Hopkins researchers targeted the Nrf2 pathway using sulforaphane, an ingredient that is present in broccoli in a precursor form, to enhance the Nrf2 pathway in the lung that mediates the uptake of bacteria. Exacerbation of symptoms due to bacterial lung infection is a common problem for many COPD patients. The current study used inflammatory cells from lungs of COPD patients and mice. The experimental therapy is also being studied in a clinical trial. COPD is major public health problem for both the developed and the developing world. Characterized by chronic bronchitis and emphysema, COPD is the third leading cause of death in the US. COPD affects 24 million Americans and 210 million worldwide. Current treatments are largely symptomatic and supportive, but do not reverse the underlying biological defect in the lung.
For the study, the researchers examined macrophages—white blood cells that kill bacteria—isolated from lungs of COPD patients. The researchers also examined mice exposed to cigarette smoke, which mimicked the immunocompromised conditions in the lungs of COPD patients. The study showed that sulforaphane could increase expression of receptors that improve macrophage phagocytic function. However, further study is needed to determine if a sulforaphane-rich diet could be an effective treatment.
"Our findings suggest that macrophages from the lungs of patients with COPD have a defect in a process called phagocytosis involved in the uptake of bacteria. We discovered that activation of the Nrf2 pathway induced by sulforaphane restored the ability of lung macrophages to bind and take up bacteria," said Shyam Biswal, PhD, professor in the Bloomberg School's Department of Environmental Health Sciences and senior author of the study. "The study provides proof of concept that activating the Nrf2 pathway can restore the ability of macrophage to phagocytose, or bind with bacteria, and clear it from the lungs of patients with COPD."
"This research may help explain the long-established link between diet and lung disease, and raises the potential for new approaches to treatment of this often devastating disease," said Robert Wise, MD, co-author of the study and professor of Medicine in the Johns Hopkins School of Medicine.
*Source: Johns Hopkins University Bloomberg School of Public Health
For the study, the researchers examined macrophages—white blood cells that kill bacteria—isolated from lungs of COPD patients. The researchers also examined mice exposed to cigarette smoke, which mimicked the immunocompromised conditions in the lungs of COPD patients. The study showed that sulforaphane could increase expression of receptors that improve macrophage phagocytic function. However, further study is needed to determine if a sulforaphane-rich diet could be an effective treatment.
"Our findings suggest that macrophages from the lungs of patients with COPD have a defect in a process called phagocytosis involved in the uptake of bacteria. We discovered that activation of the Nrf2 pathway induced by sulforaphane restored the ability of lung macrophages to bind and take up bacteria," said Shyam Biswal, PhD, professor in the Bloomberg School's Department of Environmental Health Sciences and senior author of the study. "The study provides proof of concept that activating the Nrf2 pathway can restore the ability of macrophage to phagocytose, or bind with bacteria, and clear it from the lungs of patients with COPD."
"This research may help explain the long-established link between diet and lung disease, and raises the potential for new approaches to treatment of this often devastating disease," said Robert Wise, MD, co-author of the study and professor of Medicine in the Johns Hopkins School of Medicine.
*Source: Johns Hopkins University Bloomberg School of Public Health
El Hospital Vall d'Hebron podría dar marcha atrás en algunos recortes de guardias
Una hernia en las cervicales podría dar marcha atrás en las primeras medidas ahorrativas que se aplican desde el lunes en hospitales como Vall d’Hebron. Habían suprimido a partir de las 21 horas la guardia presencial del médico adjunto del servicio de rehabilitación de Vall d'Hebron, donde se atienden, entre otros, a lesionados medulares de Catalunya, Baleares, Andorra y sur de Francia. Pero a las 21.30 del primer día de medidas especiales –para estas dos semanas– llegó un paciente con una hernia cervical con pérdida de fuerza en todo el brazo. Y no había adjunto.
“Se armó un follón tremendo”, relatan especialistas del centro que participaban en una protesta ante la conselleria. Tuvieron que ingresar al paciente, “que en condiciones normales no hubiera requerido ingreso”, y este les comunicó que de allí no se movía hasta que le operaran. La medida se ha revertido, según los médicos, y está en revisión según el hospital. Otro de los imprevistos que surgen con estas primeras medidas es el triunfo de las quejas. Una madre mostró su indignación a la dirección del hospital ante el segundo retraso de la operación de rótula de su hija. Y consiguió nueva fecha, aseguran los médicos. “El triunfo del pollo”.
En la hoja de guardias de Bellvitge crece el número de las divididas: allí, hasta las 10 de la noche, y después, localizable. Anteanoche contaban en el gran hospital con un cirujano general, un anestesista y un equipo de instrumentistas, la mitad de lo habitual. “Por la mañana quedaban pendientes una vesícula biliar infectada, una apendicitis y un absceso perineal, que no sabes cómo duele”, explican los médicos. “Y si llega a entrar un accidentado con riesgo vital, ¿esperamos a que llegue el cirujano de guardia localizable o dejamos en el quirófano la apendicitis?”, pregunta una anestesista.
También en cirugía cardiaca de Vall d’Hebron se habían tomado medidas que ahora están en revisión. Hasta ahora había un adjunto en guardia presencial y a partir de ahora se había ordenado que un adjunto estuviera localizable en casa a partir de las 5 de la tarde. A menudo atienden postoperatorios sangrantes y con problemas agudos.
Las garantías tranquilizadoras mostradas por el conseller de Salut no parecen haber surtido efecto. Trabajadores de varios hospitales cortaron el tráfico al mediodía y unos doscientos delegados de Metges de Catalunya pitaron ante su departament, pidieron la dimisión del conseller y entregaron un manifiesto contra los recortes, que “ponen en peligro la sanidad pública”. El conseller Boi Ruiz dijo en el Parlament que algunos agentes del sector sanitario han demostrado un “comportamiento irresponsable”.
**Publicado en "LA VANGUARDIA"
“Se armó un follón tremendo”, relatan especialistas del centro que participaban en una protesta ante la conselleria. Tuvieron que ingresar al paciente, “que en condiciones normales no hubiera requerido ingreso”, y este les comunicó que de allí no se movía hasta que le operaran. La medida se ha revertido, según los médicos, y está en revisión según el hospital. Otro de los imprevistos que surgen con estas primeras medidas es el triunfo de las quejas. Una madre mostró su indignación a la dirección del hospital ante el segundo retraso de la operación de rótula de su hija. Y consiguió nueva fecha, aseguran los médicos. “El triunfo del pollo”.
En la hoja de guardias de Bellvitge crece el número de las divididas: allí, hasta las 10 de la noche, y después, localizable. Anteanoche contaban en el gran hospital con un cirujano general, un anestesista y un equipo de instrumentistas, la mitad de lo habitual. “Por la mañana quedaban pendientes una vesícula biliar infectada, una apendicitis y un absceso perineal, que no sabes cómo duele”, explican los médicos. “Y si llega a entrar un accidentado con riesgo vital, ¿esperamos a que llegue el cirujano de guardia localizable o dejamos en el quirófano la apendicitis?”, pregunta una anestesista.
También en cirugía cardiaca de Vall d’Hebron se habían tomado medidas que ahora están en revisión. Hasta ahora había un adjunto en guardia presencial y a partir de ahora se había ordenado que un adjunto estuviera localizable en casa a partir de las 5 de la tarde. A menudo atienden postoperatorios sangrantes y con problemas agudos.
Las garantías tranquilizadoras mostradas por el conseller de Salut no parecen haber surtido efecto. Trabajadores de varios hospitales cortaron el tráfico al mediodía y unos doscientos delegados de Metges de Catalunya pitaron ante su departament, pidieron la dimisión del conseller y entregaron un manifiesto contra los recortes, que “ponen en peligro la sanidad pública”. El conseller Boi Ruiz dijo en el Parlament que algunos agentes del sector sanitario han demostrado un “comportamiento irresponsable”.
**Publicado en "LA VANGUARDIA"
Stanford research casts sober light on Russia's mortality crisis
With the collapse of the Soviet Union, Russians were faced with more than the demise of a political system. Working-age men began dying in droves, and the country saw a 40 percent surge in deaths between 1990 and 1994. The killer was often alcohol – that much was clear. And for years, many economists and political scientists have blamed Russia's lurch toward democracy and capitalism for driving those men to drink. They reasoned that privatization left many people unskilled and unemployable, ushering in a sense of listlessness and depression that mixed too easily with cheap vodka.
But Stanford researchers have dug up evidence that helps get democracy and capitalism off the hook and points to a new culprit: the end of an anti-alcohol campaign that contributed to a plunge in mortality rates during its short life in the Gorbachev era.
"Most things that kill people disproportionately kill babies and the elderly," said Grant Miller, an assistant professor of medicine and faculty member of the Center for Health Policy. "But working-age men accounted for the largest spike in deaths in the early 1990s. Many people suspect that's somehow entwined with political and economic transition, but there's a lot more to it than that."
Most of the deaths during Russia's mortality crisis were from alcohol poisoning, drunken violence or slower killers like heart attacks and strokes, he said.
Miller has outlined the findings – based on newly compiled and digitized archival data – in a working paper written in collaboration with associate professor of medicine Jay Bhattacharya and Christina Gathmann, an assistant professor of economics at the University of Mannheim in Germany. Their research was supported in part by the National Institutes of Health through Stanford's Center on the Demography and Economics of Health and Aging.
Their study shows a steady rise in the number of deaths between the early 1960s and 1984 in one of the world's heaviest drinking countries. Recognizing that alcoholism was a major cause of death and low work productivity, Mikhail Gorbachev instituted an aggressive anti-alcohol campaign in 1985, shortly after he became the Soviet Union's secretary general.
New regulations slashed official alcohol sales by two-thirds, drove up prices by as much as 50 percent and prohibited stores from selling booze before 2 p.m. on business days. Showing up drunk at work or on the streets could cost Russians a hefty fine or land them in prison.
"It was common practice for workers to take their breaks, go to a liquor store and come back to work drunk," said Bhattacharya, who is also a Stanford Center for Health Policy faculty member. "So the people behind the campaign thought closing the stores during the day could lead to more productivity and fewer work-related deaths and injuries."
But the campaign also emphasized alternatives to drinking. A national temperance society was formed, propaganda promoted sobriety and administrators in all Soviet districts – called oblasts – were required to build more parks and sports clubs to encourage family-friendly fun.
The campaign worked. The number of deaths plummeted in 1985 and remained below the pre-campaign trend throughout the late 1980s. That translated to a 12 percent decline in mortality rates: about 665,000 fewer deaths. But by the early 1990s, shortly after the campaign was dropped – and at the same time that the Soviet Union crumbled – the number of deaths began to climb.
The temperance campaign officially folded in 1988 for two main reasons: It was wildly unpopular and the government realized it was losing too much money from low alcohol sales. By 1991, consumption was back to pre-campaign levels.
And Russia's heaviest drinkers – working-age men – fell off the wagon and got back to dying at alarming rates. The end of the campaign accounts for as much as half of Russia's four-year mortality crisis, Miller and Bhattacharya said.
"Welfare and health are not exactly the same thing," Miller said. "You can restrict people's choices in a way that improves health, but that doesn't unambiguously mean that people are better off. "
**Source: Stanford University
But Stanford researchers have dug up evidence that helps get democracy and capitalism off the hook and points to a new culprit: the end of an anti-alcohol campaign that contributed to a plunge in mortality rates during its short life in the Gorbachev era.
"Most things that kill people disproportionately kill babies and the elderly," said Grant Miller, an assistant professor of medicine and faculty member of the Center for Health Policy. "But working-age men accounted for the largest spike in deaths in the early 1990s. Many people suspect that's somehow entwined with political and economic transition, but there's a lot more to it than that."
Most of the deaths during Russia's mortality crisis were from alcohol poisoning, drunken violence or slower killers like heart attacks and strokes, he said.
Miller has outlined the findings – based on newly compiled and digitized archival data – in a working paper written in collaboration with associate professor of medicine Jay Bhattacharya and Christina Gathmann, an assistant professor of economics at the University of Mannheim in Germany. Their research was supported in part by the National Institutes of Health through Stanford's Center on the Demography and Economics of Health and Aging.
Their study shows a steady rise in the number of deaths between the early 1960s and 1984 in one of the world's heaviest drinking countries. Recognizing that alcoholism was a major cause of death and low work productivity, Mikhail Gorbachev instituted an aggressive anti-alcohol campaign in 1985, shortly after he became the Soviet Union's secretary general.
New regulations slashed official alcohol sales by two-thirds, drove up prices by as much as 50 percent and prohibited stores from selling booze before 2 p.m. on business days. Showing up drunk at work or on the streets could cost Russians a hefty fine or land them in prison.
"It was common practice for workers to take their breaks, go to a liquor store and come back to work drunk," said Bhattacharya, who is also a Stanford Center for Health Policy faculty member. "So the people behind the campaign thought closing the stores during the day could lead to more productivity and fewer work-related deaths and injuries."
But the campaign also emphasized alternatives to drinking. A national temperance society was formed, propaganda promoted sobriety and administrators in all Soviet districts – called oblasts – were required to build more parks and sports clubs to encourage family-friendly fun.
The campaign worked. The number of deaths plummeted in 1985 and remained below the pre-campaign trend throughout the late 1980s. That translated to a 12 percent decline in mortality rates: about 665,000 fewer deaths. But by the early 1990s, shortly after the campaign was dropped – and at the same time that the Soviet Union crumbled – the number of deaths began to climb.
The temperance campaign officially folded in 1988 for two main reasons: It was wildly unpopular and the government realized it was losing too much money from low alcohol sales. By 1991, consumption was back to pre-campaign levels.
And Russia's heaviest drinkers – working-age men – fell off the wagon and got back to dying at alarming rates. The end of the campaign accounts for as much as half of Russia's four-year mortality crisis, Miller and Bhattacharya said.
"Welfare and health are not exactly the same thing," Miller said. "You can restrict people's choices in a way that improves health, but that doesn't unambiguously mean that people are better off. "
**Source: Stanford University
Differences in brain structure indicate risk for developing Alzheimer's disease
Subtle differences in brain anatomy among older individuals with normal cognitive skills may be able to predict both the risk of developing Alzheimer's disease in the following decade and how quickly symptoms of dementia would develop. In their analysis of magnetic resonance (MR) images from two separate study groups, researchers from Rush University Medical Center and Massachusetts General Hospital (MGH) found that, among individuals in whom specific brain structures were thinnest, the risk of developing Alzheimer's was three times greater than in those with above-average thickness. The study appears in April 13 issue of Neurology. "We know, primarily from postmortem studies, that changes characteristic of Alzheimer's disease can be present in the brains of cognitively normal people," says Dr. Brad Dickerson, of the MGH department of neurology, lead author of the paper. "But since it takes a long time to follow people through initial symptom development to eventual diagnosis, how that process occurs has received very little study. We used what we know about the signature brain changes seen in patients with Alzheimer's dementia, measured those areas in individuals with no symptoms and eventually determined that those who ultimately developed dementia showed subtle shrinking long before they had any symptoms."
"The MR measurements could be very important indicators to help identify who may be at risk of developing Alzheimer's dementia. If a drug therapy or treatment is developed in the future, those who are still without symptoms but at great risk would benefit the most from treatment," said Leyla deToledo-Morrell, PhD, senior author of the paper and professor in the department of neurological sciences at Rush University Medical Center.
Participants in this study, men and women in their 70s with similar levels of education, were enrolled in two long-term research investigations of brain changes in older individuals, one based at Rush and the other at MGH. Upon entering the studies, participants had a comprehensive clinical examination, neuropsychological evaluation including memory testing, and brain MR imaging. At annual follow-up visits, each was reassessed to determine whether they were cognitively normal or if they had mild cognitive impairment or probable Alzheimer's dementia.
The Neurology study analyzed data from participants who were cognitively normal at the outset and had at least four follow-up visits – a group that totaled 50 participants who remained cognitively normal at the end of the study period, and 15 who had developed Alzheimer's over an average time span of about nine years. In both study groups, the baseline MR images revealed that areas of the cerebral cortex associated with Alzheimer's in previous studies tended to be thinner in participants who went on to develop dementia.
Among those in whom these signature brain areas were the thinnest, 55 percent developed dementia during the study period, compared with 20 percent of those with average cortical thickness and none of those in whom cortical thickness was above average. Participants with the thinnest cortical areas also developed Alzheimer's significantly faster than those with average thickness.
"Comparing the data from the Chicago and Boston sites showed very similar results," said deToledo-Morrell. "Pulling together the data from both sites makes the findings that much stronger."
Adds Dickerson, who is an associate professor of Neurology at Harvard Medical School, "We believe these MR measurements can be powerful markers of the pattern of brain atrophy in Alzheimer's disease and are investigating their use in several ways, including assessing dementia risk in asymptomatic individuals. Our current results are preliminary and are not ready to be applied outside of research studies, but we are optimistic that this marker will be useful in guiding clinical care in the future."
**Source: Rush University Medical Center
"The MR measurements could be very important indicators to help identify who may be at risk of developing Alzheimer's dementia. If a drug therapy or treatment is developed in the future, those who are still without symptoms but at great risk would benefit the most from treatment," said Leyla deToledo-Morrell, PhD, senior author of the paper and professor in the department of neurological sciences at Rush University Medical Center.
Participants in this study, men and women in their 70s with similar levels of education, were enrolled in two long-term research investigations of brain changes in older individuals, one based at Rush and the other at MGH. Upon entering the studies, participants had a comprehensive clinical examination, neuropsychological evaluation including memory testing, and brain MR imaging. At annual follow-up visits, each was reassessed to determine whether they were cognitively normal or if they had mild cognitive impairment or probable Alzheimer's dementia.
The Neurology study analyzed data from participants who were cognitively normal at the outset and had at least four follow-up visits – a group that totaled 50 participants who remained cognitively normal at the end of the study period, and 15 who had developed Alzheimer's over an average time span of about nine years. In both study groups, the baseline MR images revealed that areas of the cerebral cortex associated with Alzheimer's in previous studies tended to be thinner in participants who went on to develop dementia.
Among those in whom these signature brain areas were the thinnest, 55 percent developed dementia during the study period, compared with 20 percent of those with average cortical thickness and none of those in whom cortical thickness was above average. Participants with the thinnest cortical areas also developed Alzheimer's significantly faster than those with average thickness.
"Comparing the data from the Chicago and Boston sites showed very similar results," said deToledo-Morrell. "Pulling together the data from both sites makes the findings that much stronger."
Adds Dickerson, who is an associate professor of Neurology at Harvard Medical School, "We believe these MR measurements can be powerful markers of the pattern of brain atrophy in Alzheimer's disease and are investigating their use in several ways, including assessing dementia risk in asymptomatic individuals. Our current results are preliminary and are not ready to be applied outside of research studies, but we are optimistic that this marker will be useful in guiding clinical care in the future."
**Source: Rush University Medical Center
La Psiquiatría infantil, nueva especialidad médica en España
Psiquiatría infantil, enfermedades infecciosas, emergencias y urgencias y medicina del deporte serán especialidades médicas al mismo nivel que cardiología o pediatría, por ejemplo, antes de final de año. Lo anunció ayer la ministra de Sanidad, Leire Pajín. Con ello se pone fin a años de reivindicaciones de los profesionales y los pacientes, en busca de una respuesta más eficaz a estas dolencias. Hasta ahora, la tuberculosis o el sida lo trataban internistas o microbiólogos. Y la mayoría de los profesionales que tratan a niños con problemas mentales se han formado para atender pacientes adultos o han tenido que ir al extranjero a especializarse.
La ministra también dijo que estaba en estudio la reglamentación de medicina legal y forense y de educación física y del deporte. Pajín anunció la creación de un registro de médicos que trabajan como especialistas sin tener el título oficial.
**Publicado en "EL PAIS"
La ministra también dijo que estaba en estudio la reglamentación de medicina legal y forense y de educación física y del deporte. Pajín anunció la creación de un registro de médicos que trabajan como especialistas sin tener el título oficial.
**Publicado en "EL PAIS"
40 millones de euros para financiar investigaciones de excelencia en España
El programa Severo Ochoa, que se anunció hace cuatro años, ya está listo para ver la luz. Se trata de subvencionar a los mejores centros de investigación con una convocatoria restrictiva, tanto, que la ministra de Ciencia, Cristina Garmendia, admite que es posible que no haya suficientes centros que cumplan los requisitos.
Para optar a la ayuda (cuatro millones en cuatro años, compatible con todas las demás subvenciones o créditos), los centros de investigación deberán contar con "un director científico de prestigio internacional de experiencia contrastada" y con al menos "10 investigadores principales que en los últimos cinco años hayan tenido publicaciones de impacto". Además, se trata de primar a centros concretos, no a redes o unidades virtuales.
Aparte del dinero, esta acreditación servirá para acceder en mejores condiciones a otras ayudas, a instalaciones, y se espera que sea un marchamo de garantía para conseguir mecenazgos.
Jurados internacionales decidirán quiénes son merecedores de la ayuda.
**Publicado en "EL PAIS"
Para optar a la ayuda (cuatro millones en cuatro años, compatible con todas las demás subvenciones o créditos), los centros de investigación deberán contar con "un director científico de prestigio internacional de experiencia contrastada" y con al menos "10 investigadores principales que en los últimos cinco años hayan tenido publicaciones de impacto". Además, se trata de primar a centros concretos, no a redes o unidades virtuales.
Aparte del dinero, esta acreditación servirá para acceder en mejores condiciones a otras ayudas, a instalaciones, y se espera que sea un marchamo de garantía para conseguir mecenazgos.
Jurados internacionales decidirán quiénes son merecedores de la ayuda.
**Publicado en "EL PAIS"
Subscribe to:
Comments (Atom)
CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies
Copyright © Noticia de Salud